Order Article Reprints

Hosoya T, Takahashi M, Davey C, Sese J, Honda-Kitahara M, Miyakita Y, Ohno M, Yanagisawa S, Omura T, Kawauchi D, et al. Volumetric Analysis of Glioblastoma for Determining Which CpG Sites Should Be Tested by Pyrosequencing to Predict Temozolomide Efficacy. Biomolecules. 2022; 12(10):1379. https://doi.org/10.3390/biom12101379

Hosoya, Tomohiro, Masamichi Takahashi, Calvin Davey, Jun Sese, Mai Honda-Kitahara, Yasuji Miyakita, Makoto Ohno, Shunsuke Yanagisawa, Takaki Omura, Daisuke Kawauchi, and et al. 2022. "Volumetric Analysis of Glioblastoma for Determining Which CpG Sites Should Be Tested by Pyrosequencing to Predict Temozolomide Efficacy" Biomolecules 12, no. 10: 1379. https://doi.org/10.3390/biom12101379

Hosoya, T., Takahashi, M., Davey, C., Sese, J., Honda-Kitahara, M., Miyakita, Y., Ohno, M., Yanagisawa, S., Omura, T., Kawauchi, D., Ozeki, Y., Kikuchi, M., Nakano, T., Yoshida, A., Igaki, H., Matsushita, Y., Ichimura, K., & Narita, Y. (2022). Volumetric Analysis of Glioblastoma for Determining Which CpG Sites Should Be Tested by Pyrosequencing to Predict Temozolomide Efficacy. Biomolecules, 12(10), 1379. https://doi.org/10.3390/biom12101379